Malta and Iceland strengthen cooperation on medicines regulation

26.5.2017

The Malta Medicines Authority made a cooperation agreement with the Icelandic Medicines Agency in an effort to strengthen capacity for medicines authorisations through joint assessment.  The agreement will facilitate mutual training for experts and explore the feasibility of conducting joint inspections.

Rúna Hauksdóttir Hvannberg, Executive Director of the Icelandic Medicines Agency said that “Iceland and Malta share key similarities as nations. Both are small island nations located in the European global neighbourhood. Due to common approach of sharing resources and work collaboratively, taking into consideration the expertise of each Agency individually, it is in the interest of both agencies to strengthen cooperation. We have found the Malta Medicines Authority to be an excellent partner in the European regulatory network and we look forward to further develop our collaboration for the benefit of patients”.

Professor Anthony Serracino Inglott, Chairperson of the Malta Medicines Authority stated that “during the past years the Authority signed a number of agreements with various regulators to strengthen our position as a centre of excellence for regulatory sciences and the pharmaceutical sector. These are particularly relevant in the context of recent developments such as BREXIT. Working with our Icelandic colleagues was a smooth process and the Authority is looking forward to fruitful collaboration.

Minister Helena Dalli said that such intensive activities of the Authority have resulted in a legacy of results, particularly the sustainability of the Authority and enhanced access to medicinal products for consumers. 

The agreement, supported by the Ministry for Social Dialogue, Consumer Affairs and Civil Liberties, was signed during the Heads of Medicines Agencies meeting which was held in Valletta between the 10th to 12th May 2017, hosting the heads of National Competent Authorities for the regulation of medicines in the EU.